Catalent brings 90 years of expertise in global formulation and product development, and commercial supply at scale for products in the over-the-counter, nutritional supplement, and beauty segments. Catalent partners with the industry leaders and innovators to produce more than 5,000 products marketed in 70+ countries. With a broad portfolio of consumer-preferred dose forms including softgel, gummy, soft-chew, fast-dissolve and unit-dose solutions, and a library of market-ready products, Catalent helps accelerate brands growth and deliver better products to market, faster. Headquartered in Somerset, New Jersey, the company generated nearly $4.3 billion in revenue in its 2023 fiscal year. For more information, visit www.catalent.com.